Thomas Meyer

11.2k total citations · 2 hit papers
137 papers, 7.9k citations indexed

About

Thomas Meyer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Thomas Meyer has authored 137 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 50 papers in Oncology and 22 papers in Organic Chemistry. Recurrent topics in Thomas Meyer's work include HER2/EGFR in Cancer Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Thomas Meyer is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Thomas Meyer collaborates with scholars based in Switzerland, Germany and United States. Thomas Meyer's co-authors include Helmut Mett, Elisabeth Buchdunger, Doriano Fabbro, Nicholas Lydon, J. Zimmermann, Pascal Furet, Paul W. Manley, Ann Depicker, Marcel Müller and Peter Traxler and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Thomas Meyer

136 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

1996 878 citations Elisabeth Buchdunger, J. Zimmermann et al. profile →
Nanobody-based products as research and diagnostic tools

2014 364 citations Thomas Meyer, Ann Depicker et al. profile →

Peers

Countries citing papers authored by Thomas Meyer

Since Specialization

Citations

This map shows the geographic impact of Thomas Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Meyer more than expected).

Fields of papers citing papers by Thomas Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Meyer. The network helps show where Thomas Meyer may publish in the future.

Co-authorship network of co-authors of Thomas Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Meyer. A scholar is included among the top collaborators of Thomas Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Meyer. Thomas Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photodynamic therapy mediated by aluminium-phthalocyanine nanoemulsion eliminates primary tumors and pulmonary metastases in a murine 4T1 breast adenocarcinoma model 2020 ·Journal of Photochemistry and Photobiology B Biology ·Mosar Corrêa Rodrigues, (unknown), (unknown), (unknown), (unknown), Carolin Merker, Thomas Meyer, (unknown), Tom Venus, João Paulo Figueiró Longo, Sacha Braun Chaves, Mônica Pereira Garcia, Irina Estrela‐Lopis, Ricardo Bentes Azevedo, Luís Alexandre Muehlmann	32
2	Dosimetric Quantification of Coating-Related Uptake of Silver Nanoparticles 2017 ·Langmuir ·Dajana Lichtenstein, Thomas Meyer, Linda Böhmert, (unknown), Christoph Fahrenson, Sören Selve, Andreas F. Thünemann, Jan Meijer, Irina Estrela‐Lopis, Albert Braeuning, Alfonso Lampen	15
3	Impact of an Artificial Digestion Procedure on Aluminum-Containing Nanomaterials 2017 ·Langmuir ·Holger Sieg, Claudia Kästner, Benjamin Krause, Thomas Meyer, Agnès Burel, Linda Böhmert, Dajana Lichtenstein, Harald Jungnickel, Jutta Tentschert, Peter Laux, Albert Braeuning, Irina Estrela‐Lopis, Fabienne Gauffre, Valérie Fessard, (unknown), Andreas Luch, Andreas F. Thünemann, Alfonso Lampen	40
4	Photo-enhanced magnetization in Fe-doped ZnO nanowires 2016 ·Applied Physics Letters ·I. Lorite, Yogesh Kumar, P. Esquinazi, (unknown), Álan Gomes Pöppl, (unknown), Jan Meijer, Marius Grundmann, Thomas Meyer, Irina Estrela‐Lopis	4
5	Organization of fluorescent cholesterol analogs in lipid bilayers — Lessons from cyclodextrin extraction 2013 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Sigrid Milles, Thomas Meyer, Holger A. Scheidt, Roland Schwarzer, Lars Thomas, Magdalena Marek, Lajos Szente, Robert Bittman, Andreas Herrmann, Thomas Günther Pomorski, Daniel Huster, Peter Müller	34
6	Production of Camel-Like Antibodies in Plants 2012 ·Methods in molecular biology ·Sylvie De Buck, Vikram Virdi, Thomas Meyer, (unknown), (unknown), Jonah Nolf, (unknown), Annelies De Paepe, Ann Depicker	19
7	Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities 2009 ·International Journal of Hyperthermia ·(unknown), Thomas Meyer, (unknown), Susanne Merkel, Jonas Goehl, Werner Hohenberger, Christian Knorr	17
8	Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases 2009 ·Journal of Surgical Oncology ·Susanne Merkel, (unknown), Thomas Meyer, Volker Müller, Thomas Papadopoulos, Werner Hohenberger	32
9	Downstaging of Pancreatic Carcinoma after Neoadjuvant Chemoradiation 2009 ·Strahlentherapie und Onkologie ·(unknown), Gerhard G. Grabenbauer, Henriette Golcher, Thomas Meyer, Thomas Papadopoulos, Werner Hohenberger, Rolf Sauer, Thomas Brunner	32
10	An ELISA for PDGFR phosphorylation: Comparison of effects of STI571 on cellular Bcr-Abl, c-Kit and PDGFR-β protein kinases 2004 ·Cancer Research ·Paul W. Manley, Juergen Mestan, Thomas Meyer, Doriano Fabbro	1
11	Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases 2004 ·Bioorganic & Medicinal Chemistry Letters ·Paul W. Manley, Werner Breitenstein, Josef Brüggen, Sandra W. Cowan‐Jacob, Pascal Furet, Jürgen Mestan, Thomas Meyer	47
12	The surgeon as a cost factor. Cost analysis exemplified by surgical treatment of rectal carcinoma 2002 ·Chirurg ·Thomas Meyer, Susanne Merkel, (unknown), W. Hohenberger	3
13	Le PKC 412 1999 ·Bulletin du Cancer ·Amélie Lansiaux, Doriano Fabbro, Thomas Meyer, François Hamy, Christian Bailly	1
14	An isopeptide bond splitting enzyme from Hirudo medicinalis similar to γ‐glutamyl transpeptidase 1998 ·European Journal of Biochemistry ·Thomas Friedrich, Burkhard Kröger, (unknown), (unknown), Thomas Meyer, Siegfried Bialojan	9
15	Phenylamino‐Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC) 1996 ·Archiv der Pharmazie ·J. Zimmermann, Giorgio Caravatti, Helmut Mett, Thomas Meyer, Marcel Müller, Nicholas Lydon, (unknown)	60
16	Different Susceptibility of Protein Kinases to Staurosporine Inhibition 1995 ·European Journal of Biochemistry ·Flavio Meggio, Arianna Donella Deana, Maria Ruzzene, Anna Maria Brunati, Luca Cesaro, Bárbara Guerra, Thomas Meyer, Helmut Mett, Doriano Fabbro, Pascal Furet, Grażyna Dobrowolska, Lorenzo A. Pinna	242
17	Protein Tyrosine Kinase and Protein Kinase C Inhibition by Fungal Anthraquinones Related to Emodin. 1995 ·The Journal of Antibiotics ·Andreas Fredenhagen, Helmut Mett, Thomas Meyer, Elisabeth Buchdunger, Urs Regenass, (unknown), Frank Petersen	27
18	Molecular characterization of human and bovine endothelin converting enzyme (ECE‐1) 1994 ·FEBS Letters ·Martin Schmidt, Burkhard Kröger, Elard Jacob, H. Seulberger, Thomas Subkowski, Rainer Otter, Thomas Meyer, Günther Schmalzing, Heinz Hillen	162
19	Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase 1991 ·Journal of Medicinal Chemistry ·Peter Traxler, (unknown), (unknown), Johanna Geissler, W. G. Kump, Thomas Meyer, Urs Regenass, Johannes Roesel, Nicholas Lydon	49
20	Antagonism of Interferon Induction in Spleen and Adherent Peritoneal Cells of Mice by the Lipophilic Antiviral Muramyl Peptide MTP-PE 1986 ·Journal of Interferon Research ·Thomas Meyer, F.M. Dietrich, (unknown), H. K. Hochkeppel	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact